Compare COO & TXRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | TXRH |
|---|---|---|
| Founded | 1980 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 11.0B |
| IPO Year | N/A | 2004 |
| Metric | COO | TXRH |
|---|---|---|
| Price | $81.98 | $165.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | $85.82 | ★ $189.47 |
| AVG Volume (30 Days) | ★ 3.3M | 1.0M |
| Earning Date | 12-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | N/A | ★ 12.56 |
| EPS | 1.87 | ★ 6.55 |
| Revenue | $4,092,400,000.00 | ★ $5,833,958,000.00 |
| Revenue This Year | $6.66 | $11.90 |
| Revenue Next Year | $5.54 | $10.41 |
| P/E Ratio | $43.53 | ★ $25.38 |
| Revenue Growth | 5.06 | ★ 14.40 |
| 52 Week Low | $61.78 | $148.73 |
| 52 Week High | $104.47 | $199.99 |
| Indicator | COO | TXRH |
|---|---|---|
| Relative Strength Index (RSI) | 72.89 | 44.55 |
| Support Level | $75.25 | $165.70 |
| Resistance Level | $78.69 | $178.68 |
| Average True Range (ATR) | 2.48 | 3.80 |
| MACD | 0.47 | -0.42 |
| Stochastic Oscillator | 55.39 | 3.70 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.